Casma Therapeutics IPO

Casma Therapeutics is a biopharma technology company that focuses on removal of damaged cell components to treat and prevent various diseases. Casma Therapeutics aims to reprogram autophagy methods, also known as the removal of infiltrates of cells that can damage and degrade them. The private company has brought together a team of clinical specialists and scientists all with a mission to treat patients where traditional drugs have failed.

Register for Details

For more details on financing and valuation for Casma Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Casma Therapeutics

Forge green plus iconForge green minus icon

What is Casma Therapeutics's IPO price?

The IPO price for Casma Therapeutics will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Casma Therapeutics?

Casma Therapeutics is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Casma Therapeutics shares pre-IPO?

If you own Casma Therapeutics pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Casma Therapeutics a publicly traded company?

Casma Therapeutics is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

When was Casma Therapeutics founded?

Casma Therapeutics was founded in 2017.

Who are Casma Therapeutics's major investors?

Euclidean Capital
Amgen Ventures
Mirae Asset Capital
Third Rock Ventures
The Column Group
Schroder Adveq
ONO Venture Investment
Mirae Asset
Eventide
Eisai Co., Ltd.
Astellas Venture Management LLC
Updated on: Nov 15, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.